The impact of initial symptoms on survival time in advanced non-small cell lung cancer

被引：0
|
作者：
Miyawaki, T. [1 ]
Yagishita, S. [2 ]
Ko, R. [3 ]
Suzuki, Y. [1 ]
Matsumoto, N. [1 ]
Hara, M. [1 ]
Iwakami, N. [1 ]
Fujii, M. [1 ]
Iwakami, S-I. [1 ]
Takahashi, K. [3 ]
机构：
[1] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan
[2] Juntendo Univ, Urayasu Hosp, Dept Resp Med, Urayasu, Japan
[3] Juntendo Univ Hosp, Dept Resp Med, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
479P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Improvement of survival for non-small cell lung cancer over time
    Xia, Wenjie
    Yu, Xinnian
    Mao, Qixing
    Xia, Wenying
    Wang, Anpeng
    Dong, Gaochao
    Chen, Bing
    Ma, Weidong
    Xu, Lin
    Jiang, Feng
    ONCOTARGETS AND THERAPY, 2017, 10 : 4295 - 4302
  • [12] Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis
    Song, Zhengbo
    Lin, Baochai
    Shao, Lan
    Zhang, Yiping
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (10) : 1613 - 1617
  • [13] Impact of novel agent therapy on survival of patients with advanced non-small cell lung cancer in Lebanon
    Massoud, M. A.
    Azar, K.
    Zeghondy, J. Z.
    Akoury, E.
    Makdessi, J.
    Sakr, R.
    ANNALS OF ONCOLOGY, 2022, 33 : S1579 - S1579
  • [14] TTF1 EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER: IMPACT ON SURVIVAL OUTCOME
    Elsamany, S.
    Al-fayea, T.
    Abozeed, W. N.
    Alzahrani, A.
    Farooq, M. U.
    Darwish, W.
    Almadani, A.
    Bukhari, E.
    ANNALS OF ONCOLOGY, 2015, 26
  • [15] Survival benefits associated with surgery for advanced non-small cell lung cancer
    David, Elizabeth A.
    Andersen, Stina W.
    Beckett, Laurel A.
    Melnikow, Joy
    Clark, James M.
    Brown, Lisa M.
    Cooke, David T.
    Kelly, Karen
    Canter, Robert J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (04): : 1620 - 1628
  • [16] Serum antioxidant levels and survival time in advanced non-small cell lung cancer patients.
    Wirasorn, Kosin
    Hongprabhas, Pranithi
    Pisprasert, Veeradej
    Klarod, Kulthida
    Boonsiri, Patcharee
    CANCER RESEARCH, 2013, 73 (08)
  • [17] Time to Progression as a Surrogate Marker for Overall Survival in Patients with Advanced Non-small Cell Lung Cancer
    Hotta, Katsuyuki
    Fujiwara, Yoshiro
    Matsuo, Keitaro
    Kiura, Kutsuyuki
    Takigawa, Nagio
    Tabata, Masahira
    Tanimoto, Mitsune
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 311 - 317
  • [18] Lead time in the evaluation of historical survival improvements in the treatment of advanced non-small cell lung cancer
    Martins, R
    Ramsey, SD
    Blough, D
    VALUE IN HEALTH, 2005, 8 (06) : A33 - A33
  • [19] Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer
    Oi, H.
    Taniguchi, H.
    Kondoh, Y.
    Kimura, T.
    Kataoka, K.
    Matsuda, T.
    Yokoyama, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2082 - S2082
  • [20] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
12345